Oncologists Accepting ConnectiCare in Boston, MA
129 verified oncologists in Boston, Massachusetts accept ConnectiCare. Profiles cover focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Newton-wellesley Hospital.
Ursula Matulonis, MD
Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute
Oncology
Robert Haddad, MD
Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School
Oncology
Mary-Ellen Taplin, MD
Professor of Medicine, Harvard Medical School; Institute Physician and Director of Clinical Research, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Oncology
Muneeb Ahmed, M.D.
Miriam H. Stoneman Professor of Radiology, Harvard Medical School; Chief, Division of Vascular and Interventional Radiology, Beth Israel Deaconess Medical Center; Chair of the Imaging Department, Dana-Farber Cancer Institute
Oncology
Susana Campos, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School
Oncology
Suzanne George, MD
Chief, Division of Sarcoma; Clinical Research Director, Sarcoma Center; Associate Professor of Medicine, Harvard Medical School
Oncology
Joseph Antin, MD
Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus
Oncology
Robert Soiffer, MD
Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School
Oncology
Harold Burstein, MD PHD
Director of Academic Partnerships; Director of Breast Cancer Education
Oncology
Liangge Hsu, MD
Assistant Professor of Radiology
Oncology
Arnold Freedman, MD
Professor of Medicine at Harvard Medical School, a member of Dana-Farber Cancer Institute's Department of Medical Oncology, and an attending physician at Brigh; Professor of Medicine, Harvard Medical School
Oncology
Erica Mayer, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program
Oncology
William Mayo-Smith, MD
Professor of Radiology
Oncology
Ann Partridge, MD MPH
Chief Clinical Strategy Officer, Vice Chair of Medical Oncology, and founder and director of Young and Strong, the Program for Young Adults with Breast Can; Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on you
Oncology
Jeremy Abramson, MD
Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School
Oncology
Elizabeth Buchbinder, M.D.
Assistant Professor of Medicine, Harvard Medical School
Oncology
Filipa Lynce, M.D.
Assistant Professor of Medicine, Harvard Medical School; Associate Director, Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute
Oncology
Raphael Bueno, M.D.
Chief, Division of Thoracic Surgery
Oncology
Neil Horowitz, MD
Surgical Director, Gynecologic Oncology; Director, Clinical Research in Gynecologic Oncology; Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School
Oncology
George Demetri, MD
Professor of Medicine, Harvard Medical School; Director, Sarcoma Center, Dana-Farber Cancer Institute; Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Co-Director, Ludwig Center at Dana-Farber/Harvard
Oncology